未登录.png)
分享.png)
收藏分享 收藏 Expert Consensus on Cytomegalovirus Management in Recipients of CAR-T Cell and Bispecific Antibody TherapiesCAR-T细胞和双特异性抗体治疗受者巨细胞病毒管理专家共识
Cao, Wenyue; Meng, Fankai; Feng, Sizhou; Zhao, Mingfeng; Song, Jianxin; Sun, Yuqian; Cao, Weijie; Tian, Weiwei; Hu, Yongxian; Fan, Fangyi; Tang, Xiaowen; Qian, Wenbin; Zhang, Yicheng; Wei, Jia 分享 收藏 CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaHu, Yongxian; Zhou, Yali; Zhang, Mingming; Ge, Wengang; Li, Yi; Yang, Li; Wei, Guoqing; Han, Lu; Wang, Hao; Yu, Shuhui; Chen, Yi; Wang, Yanbin; He, Xiaohong; Zhang, Xingwang; Gao, Ming; Yang, Jingjing; Li, Xiuju; Ren, Jiangtao; Huang, He 分享 收藏 Potent Anti-leukemia Activities of Chimeric Antigen Receptor-Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic LeukemiaHu, Yongxian; Wu, Zhao; Luo, Yi; Shi, Jimin; Yu, Jian; Pu, Chengfei; Liang, Zuyu; Wei, Guoqing; Cui, Qu; Sun, Jie; Jiang, Jing; Xie, Jue; Tan, Yamin; Ni, Wanmao; Tu, Jifang; Wang, Jinping; Jin, Aiyun; Zhang, Hao; Cai, Zhen; Xiao, Lei; Huang, He 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
